Cinacalcet Tablet, Film Coated
Product Images NDC 16729-441

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cinacalcet (NDC 16729-441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Mean (se) Ipth Values (pooled Phase 3 Studies) (Cinacalcet 01)

Not available.*

FDA Label Image

Figure 2. Mean (se) Ca X P Values (pooled Phase 3 Studies) (Cinacalcet 02)

FDA Label Image

Figure 3. Serum Calcium Values In Patients With Parathyroid Carcinoma Receiving Sensipar At Baseline, Titration, And Maintenance Phase (Cinacalcet 03)

FDA Label Image

Figure 4. Mean Serum Calcium (se) At Baseline, End Of Titration, And Scheduled Maintenance Visits (patients With Severe Intractable Primary Hpt) (Cinacalcet 04)

FDA Label Image

Principal Display Panel (Cinacalcet 30mg 30tab Lab)

This is a description of a medication called Cinacalcet with dosage information provided in the package insert. The tablets are coated and come in a package with NDC code 16729-440-10, with a dosage of 30mg per tablet. The medication is used for treatment of conditions relating to excessive parathyroid hormone. The tablets should be stored between 15°C to 30°C, (59°F to 86°F), and in a light-resistant container. The manufacturer of this medication is Accord Healthcare, Inc, located in Durham, NC 27703, and it is manufactured by Intas Pharmaceuticals Limited, based in Ahmedabad, India.*

FDA Label Image

Principal Display Panel (Cinacalcet 60mg 30tab Lab)

Each film-coated tablet contains 60 mg of cinacalcet hydrochloride. The dosage information can be found in the package insert. The tablets should be stored at 25°C, with excursions permitted from 15°C to 30°C. They should be dispensed in a tight, light-resistant container as per USP. They are manufactured for Accord Healthcare Inc. in Durham, NC, and were made by Infas Pharmacicas Limed in Ahmedabad, India. A total of 30 tablets are included.*

FDA Label Image

Principal Display Panel (Cinacalcet 90mg 30tab Lab)

Each film-coated tablet contains 90mg of cinacalcet hydrochloride, also known as cinacalcet NDC 16729-442-10. The dosage is available in the package insert, and the tablets should be stored at a temperature range of 15°C to 30°C (59°F to 86°F). The container should be light-resistant and tightly closed per USP regulations. Manufactured by Accord Healthcare, Inc. in Durham, NG 27703, and Infas Pharmaceuticals Limited, in Ahmedabad-382 210, India. This product is available by prescription only.*

FDA Label Image

The Following Structural Formula For Hydrochloride Salt Of Cinacalcet Is Described Chemically As N-[1-(r)-(-)-(1-naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]-1-aminopropane Hydrochloride. (Cinacalcet Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.